Literature DB >> 27443784

Ionotropic glutamate receptor expression in human white matter.

Pia Crone Christensen1, Zahra Samadi-Bahrami2, Vlady Pavlov2, Peter K Stys3, G R Wayne Moore2.   

Abstract

Glutamate is the key excitatory neurotransmitter of the central nervous system (CNS). Its role in human grey matter transmission is well understood, but this is less clear in white matter (WM). Ionotropic glutamate receptors (iGluR) are found on both neuronal cell bodies and glia as well as on myelinated axons in rodents, and rodent WM tissue is capable of glutamate release. Thus, rodent WM expresses many of the components of the traditional grey matter neuron-to-neuron synapse, but to date this has not been shown for human WM. We demonstrate the presence of iGluRs in human WM by immunofluorescence employing high-resolution spectral confocal imaging. We found that the obligatory N-methyl-d-aspartic acid (NMDA) receptor subunit GluN1 and the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunit GluA4 co-localized with myelin, oligodendroglial cell bodies and processes. Additionally, GluA4 colocalized with axons, often in distinct clusters. These findings may explain why human WM is vulnerable to excitotoxic events following acute insults such as stroke and traumatic brain injury and in more chronic inflammatory conditions such as multiple sclerosis (MS). Further exploration of human WM glutamate signalling could pave the way for developing future therapies modulating the glutamate-mediated damage in these and other CNS disorders.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  AMPA; CNS; Ionotropic glutamate receptor; NMDA; Spectral confocal microscopy; White matter

Mesh:

Substances:

Year:  2016        PMID: 27443784     DOI: 10.1016/j.neulet.2016.07.030

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

Review 1.  Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Authors:  Kasper B Hansen; Lonnie P Wollmuth; Derek Bowie; Hiro Furukawa; Frank S Menniti; Alexander I Sobolevsky; Geoffrey T Swanson; Sharon A Swanger; Ingo H Greger; Terunaga Nakagawa; Chris J McBain; Vasanthi Jayaraman; Chian-Ming Low; Mark L Dell'Acqua; Jeffrey S Diamond; Chad R Camp; Riley E Perszyk; Hongjie Yuan; Stephen F Traynelis
Journal:  Pharmacol Rev       Date:  2021-10       Impact factor: 18.923

2.  Vesicular glutamate release from central axons contributes to myelin damage.

Authors:  Sean Doyle; Daniel Bloch Hansen; Jasmine Vella; Peter Bond; Glenn Harper; Christian Zammit; Mario Valentino; Robert Fern
Journal:  Nat Commun       Date:  2018-03-12       Impact factor: 14.919

3.  Calcium Influx through Plasma-Membrane Nanoruptures Drives Axon Degeneration in a Model of Multiple Sclerosis.

Authors:  Maarten E Witte; Adrian-Minh Schumacher; Christoph F Mahler; Jan P Bewersdorf; Jonas Lehmitz; Alexander Scheiter; Paula Sánchez; Philip R Williams; Oliver Griesbeck; Ronald Naumann; Thomas Misgeld; Martin Kerschensteiner
Journal:  Neuron       Date:  2019-01-24       Impact factor: 17.173

4.  Reduction of AMPA receptor activity on mature oligodendrocytes attenuates loss of myelinated axons in autoimmune neuroinflammation.

Authors:  Kirsten S Evonuk; Ryan E Doyle; Carson E Moseley; Ian M Thornell; Keith Adler; Amanda M Bingaman; Mark O Bevensee; Casey T Weaver; Booki Min; Tara M DeSilva
Journal:  Sci Adv       Date:  2020-01-08       Impact factor: 14.136

5.  Testing the Role of Glutamate NMDA Receptors in Peripheral Trigeminal Nociception Implicated in Migraine Pain.

Authors:  Cindy Guerrero-Toro; Kseniia Koroleva; Elizaveta Ermakova; Oleg Gafurov; Polina Abushik; Pasi Tavi; Guzel Sitdikova; Rashid Giniatullin
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.